Mitigating Risk of Validated Analytical Procedure Failures When Upgrading or Replacing LC Assets: Harnessing the Power of Quality by Design (QbD) Principles

[ CASE STUDY ] Risk-based Approach Supports Migration of Legacy Methods for Eurofins BPT Toronto Eurofins BioPharma Product Testing division assessed the Waters ACQUITY Arc HPLC System for the migration of legacy methods in a regulated environment to ensure consistency…

GAIN GREATER CONFIDENCE AGILENT SOLUTIONS FOR QUALITY-BY-DESIGN IMPLEMENTATION IN PHARMACEUTICAL DEVELOPMENT Primer CONTENTS INTRODUCTION: AN OVERVIEW OF QUALITY BY DESIGN......................................................................................3 ELIMINATING VARIABILITY IN ANALYTICAL METHOD DEVELOPMENT...........................................................................5 Automated Method Development Solution with Multivariate Analysis for Evaluation of Design Space...................................................................................................... 7 Instrument…

Regulations for Analytical development USFDA/ICH/USP perspectives Manu Grover M.S (Pharma) Business Development ManagerPharma Markets Santa Clara (US) [email protected] DE94720144 Outline ICH Guidelines and USP chapters Method development guidelines from ICH Journey of Method development related regulations. • ICH Q2(R2) •…

Application Note Development of a Robust Method for Analysis of Aspirin and Related Substances Using a Statistical Software and Quality-byDesign Approach Margaret Maziarz, Paul D. Rainville, Tran Pham Waters Corporation Abstract Aspirin is a class of medication available by prescription…